RPRX

Repros Therapeutics Inc.
RPRX

Overview Fund Activity
Delisted

RPRX was delisted on the 31st of January, 2018.

Back to rankings

56 hedge funds and large institutions have $12.3M invested in Repros Therapeutics Inc. in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 18 closing their positions.

Holders
56
Holders Change
-2
Holders Change %
-3.45%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
13
Reduced
16
Closed
18
Calls
$564K
Puts
$342K
Net Calls
+$222K
Net Calls Change
-$9.09M

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$897K
2
ARTA
2
A.R.T. Advisors
New York
$220K
3
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$327K
4
BIM
4
Bogle Investment Management
Massachusetts
$195K
5
VKH
5
Virtu KCG Holdings
New York
$98K

Top Sellers

1
BBA
1
Baker Bros. Advisors
New York
$0
2
DCM
2
Destrier Capital Management
New York
$0
3
HCMT
3
Highland Capital Management (Texas)
Texas
$0
4
RI
4
RTW Investments
New York
$0
5
PA
5
Perceptive Advisors
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
KTC
76
Kistler-Tiffany Companies
Pennsylvania
$0 270 – –
OPPM
77
Opus Point Partners Management
New York
– – – –
ST
78
Spot Trading
Illinois
$0 150 +150 New
1 2 3
4